Surgical Stent Market 2018 Upgrading a Foster Growth by Increasing Demand of Dental Implants | Unleashing Forecast by MRFR till 2023 Market Research Future published a research report on Global Surgical Stent Market and the report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions. The stent is a small, flexible metal or plastic tube that are inserted into the vessels or duct to keep the passageway open. Different types of materials like metal, standard polymer, and biodegradable polymer are used for the preparation of the surgical stents. The Global Surgical Stent Market is projected to grow at a CAGR of 7.9% during the forecast period 2017-2023. According to the WHO (2015), more than 35% of the total global population was suffering from major or minor cardiovascular complications; and in 2014, globally 39% of adults aged 18 years and over were overweight whereas, 13% were obese. Thus, increasing prevalence of diabetes and obesity have increased the risk of urinary tract failure. Major driving factors for the growth of the market: Increasing prevalence of cardiovascular diseases, rising diabetic & obese population and rapid development in the technology. Moreover, rising healthcare expenditure, increasing geriatric population, and changing lifestyle have fueled the growth of the market. Get Sample PDF Illustration @ https://www.marketresearchfuture.com/sample_request/1044 Key Players for Global Surgical Stent Market STI Laser Industries, Ltd (Israel), ELLA - CS, s.r.o. (Czech Republic), Boston Scientific Corporation (US), Laserage Technology corporation (US), amg International GmbH (Germany), Abbott (US), Angiocare (Netherlands), Meril Life Sciences Pvt. Ltd. (India), Elixir Medical Corporation (US), F. Hoffmann-La Roche Ltd. (Switzerland), B. Braun Melsungen AG (Germany), Medtronic (US), Amaranth Medical, Inc (US), Arterial Remodeling Technologies (US) are some of the prominent players at the forefront of competition in the Surgical Stents Market and are profiled in MRFR Analysis. Surgical Stent Market Competitive Landscape The global surgical stents market is experiencing extreme competition due to major companies are focusing on the development of biodegradable stents to overcome the disadvantages of other available stents. Some major has adopted strategies of acquisitions and strategic alliances for the growth of the market. Boston Scientific Corporation, headquartered in the US, is a global manufacturer and developer of medical devices. The company has adopted various strategies to sustain in the competitive market, for instance, new products launch. PROMUS Element Plus Stent, REBEL Stent System, SYNERGY Stent are some of the major products of the company. In 2015, worldwide sales of the company’s drug-eluting coronary stents were $1.074 billion as compared to $1.151 billion during 2014. Abbott, headquartered in US, is one of the leading healthcare company. In June 2016, FDA has approved the Absorb bioresorbable Stent for heart. This stents is completely
Surgical Stent Market 2018 Upgrading a Foster Growth by Increasing Demand of Dental Implants | Unlea
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.